Guardion Health Sciences' GAAP loss for 3 months of 2022 was $2.618 million, down 1.9% from $2.669 million in the prior year. Revenue increased 10.24 times to $2.385 million from $0.233 million a year earlier.
Guardion Health Sciences' GAAP loss for 3 months of 2022 was $2.618 million, down 1.9% from $2.669 million in the prior year. Revenue increased 10.24 times to $2.385 million from $0.233 million a year earlier. 
English (US) 